That's pretty good for people coming in for non-treatment. We didn't even provide counseling unless they asked for it.
It's absolutely worth it. There's a lot of promise for this vaccine, not just because of our study, but also because of other studies.
It's such a novel way of treating an addiction because it's not targeting any part of the brain. It's targeting the molecule itself.
The vaccine works by producing antibodies that specifically bind to nicotine, and thereby prevent much of the nicotine from entering the brain. This process potentially reduces the pleasurable effects from smoking and reduces the addiction to nicotine.
Far more people quit in the highest dose. It looks like vaccines do have promise in terms of helping people quit smoking.
This result was an impressive and completely unexpected study.
This result was an impressive and completely unexpected finding because the study was not focused on helping smokers quite smoking. In fact, to participate in the study, smokers had to attest that they did not have a planned quit date for the next six months.
